Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
18 other companies have their registered office at the same address; threshold 10.
No annual accounts yet
This company hasn't filed annual accounts with the National Bank yet. As soon as one arrives, the analysis appears here.
What happened to Fibrocor Therapeutics Europe?
What happened at Fibrocor Therapeutics Europe in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New establishment in Brussel. KBO
- Start of the company according to the CBE. KBO
A new publication or filing at Fibrocor Therapeutics Europe? We notify you, reason included.
Follow Fibrocor Therapeutics EuropeEstablishments
Establishment units
Physical locations of this company
Barricadenplein 13
1000 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 18 companies are registered at this address.
All companies at this address →Société Coopérative pour le Développement Industriel en Afrique
Société des Habitations à Bon Marché
Domein van Vorselaar
€ 182,308 gross margin · 2025
DE BEUKEN
€ -14,127 gross margin · 2025
MERISANT EUROPE
€ 66,970 gross margin · 2025
+13 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1025.566.152
- VAT number
- BE 1025.566.152
- Registered office
- Barricadenplein 13, 1000 Brussel
- Names & denominations
- Fibrocor Therapeutics Europe
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 July 2025
- Peppol
- Active · Active since 22 Dec 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied